8 Best Stocks to Buy for High Returns in 2024
The broader market reached new record highs on October 11, driven by financial stocks posting stronger-than-expected quarterly results. Adding to investor optimism is the recent decline in U.S.
Jazz Pharmaceuticals Plc (JAZZ)
Market is closed
Sector: Pharmaceutical Preparations
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Vestal Point Capital Ryan Wilder | 1,500,000 | $160,095,000 | +37% | 11.93% |
| 2. | Polaris Capital Management Bernard Horn | 1,375,460 | $146,802,846 | -4% | 8.19% |
| 3. | Renaissance Technologies Jim Simons | 1,025,868 | $109,490,892 | -12% | 0.18% |
| 4. | EcoR1 Capital Oleg Nodelman | 1,013,952 | $108,219,097 | 3.31% | |
| 5. | AQR Capital Management Cliff Asness | 619,100 | $66,076,543 | -17% | 0.1% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $119.65 | 12,000 | Officer | 27,932 | 2024-03-01 | Filing | |
| $112.32 | 11,482 | Director | 1,152,788 | 2020-05-27 | Filing | |
| $111.56 | 9,884 | Director | 1,141,306 | 2020-05-27 | Filing | |
| $110.52 | 8,391 | Director | 1,131,422 | 2020-05-27 | Filing | |
| $109.55 | 5,243 | Director | 1,123,031 | 2020-05-27 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $108.30 | 1,410 | Officer | 14,531 | 2024-09-06 | Filing | |
| $108.83 | 163 | Officer | 6,596 | 2024-06-07 | Filing | |
| $109.65 | 5,000 | Officer | 36,629 | 2024-05-03 | Filing | |
| $116.98 | 1,768 | Officer | 6,596 | 2024-03-07 | Filing | |
| $117.51 | 700 | Officer | 8,364 | 2024-03-06 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 7,056,032 | $867,891,936 | 0.02% | |
| 2. | 6,363,748 | $782,741,004 | 0.01% | |
| 3. | 2,421,125 | $297,798,375 | 0.01% | |
| 4. | 1,397,284 | $171,865,938 | 0.01% | |
| 5. | 1,312,771 | $161,470,833 | 0.04% |
News See All
10 Most Promising Biotech Stocks According to Hedge Funds
Biotechnology stocks are known for their high risk, making them some of the most volatile in the market.
Piper Sandler's Top Technical Stock Picks: 20 Best Stocks
The start of October has seen another wild swing for markets. September's second half saw Wall Street rejoice as the Federal Reserve delivered its highly anticipated interest rate cut.
8 Most Undervalued Growth Stocks To Buy According To Wall Street Analysts
Analysts and the market blamed the Fed for not cutting the interest rate earlier in July. However, the sentiments seemed to have shifted with the recent jobs report with above-expectation data.
7 Best Small-Cap Value Stocks to Buy According to Hedge Funds
Today's AI-fueled era of the "Magnificient Seven" technology stocks is dominating the US stock market. However, investing with a focus on value stocks hasn't lost its popularity.
10 Stocks with Biggest Upside Potential According to Hedge Funds
The US equities saw a strong move after the September jobs report exceeded the economists’ estimates.
Seth Klarman Stock Portfolio: Top 10 Stock Picks
Seth Klarman, the founder and CEO of Baupost Group, is a prominent figure in the investment industry, with his hedge fund ranking as the 12th largest globally.
8 Best Cheap Growth Stocks To Invest In Now
The current market data shows that the economy of the United States is normalizing, especially with an active Federal Reserve, global stimulus from China, and higher consumption rates.
10 Best Mid-Cap Healthcare Stocks To Buy Now
According to projections by ReportLinker, the market for healthcare services will increase from $7.5 trillion in 2022 to $7.975 trillion in 2023.
Top 10 ADR Stocks To Buy According to Hedge Funds
Diversifying an investment portfolio is one of the best ways of spreading risk and minimizing the impact of heightened volatility.
Billionaire Hedge Funds
